AstraZeneca Settles Pulmicort War With Teva
Coaxed by favorable royalty rates and an affirmation of its patents, AstraZeneca PLC has agreed to let Teva Pharmaceuticals Ltd. market a generic version of Pulmicort Respules, AstraZeneca's asthma medication, bringing...To view the full article, register now.
Already a subscriber? Click here to view full article